Transcriptomics

Dataset Information

0

Development of DNA demethylation technology in HEK293T cells


ABSTRACT: DNA demethylating agents are epigenetic drugs for the therapy of myeloid leukemias. They not only induce DNA demethylation but also have significant cytostatic and cytotoxic effects, however, the relationships between these characteristics have not been established yet due to the lack of method to induce only DNA demethylation. Here we show that a fusion protein comprising the methyl-CpG binding domain (MBD) and the catalytic domain of Ten-eleven translocation protein 1 (TET1-CD) globally demethylates and upregulates a number of methylated genes. Gene expression microarray analyses using human embryonic kidney cell line 293T indicate that cells expressing wild-type (wt) TET1 catalytic domain with MBD (MBD-TET1-CDwt) upregulated more genes than ones expressing TET1-CDwt without MBD or catalytically inactive TET1-CD mutant (mut) with MBD (MBD-TET1-CDmut) and their upregulated genes frequently contained CpG islands (CGIs) within ± 1,000 bp of the transcription start site (TSS). Interestingly, 88% of genes upregulated 5-fold or more by MBD-TET1-CDwt were also reactivated after treatment with DNA demethylating agent, 5-azacytidine, suggesting that gene reactivation by both methods is primarily based on DNA demethylation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE74744 | GEO | 2017/02/09

SECONDARY ACCESSION(S): PRJNA301398

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-06-04 | E-GEOD-44036 | biostudies-arrayexpress
2014-06-04 | E-GEOD-50016 | biostudies-arrayexpress
2014-06-04 | E-GEOD-49833 | biostudies-arrayexpress
2014-06-04 | E-GEOD-44038 | biostudies-arrayexpress
2011-06-03 | E-GEOD-25981 | biostudies-arrayexpress
2014-06-04 | GSE49833 | GEO
2014-06-04 | GSE44036 | GEO
2014-06-04 | GSE44038 | GEO
2014-06-04 | GSE50016 | GEO
2022-08-11 | PXD028566 | Pride